Resource Logo
NLM AIDSLINE

Off label drug promotion.




 

Body Posit. 1998 Oct;XI(10):11. Unique Identifier : AIDSLINE

AIDS advocates have expressed concern over a Federal judge's ruling. The ruling states that the Food and Drug Administration (FDA) must allow pharmaceutical companies to distribute information about off-label uses for their FDA approved drugs. The advocates contend that the ruling will give drug manufacturers less incentive to conduct clinical research on their drugs.

NEWSLETTER ARTICLE Advertising/LEGISLATION & JURISPRUD Drug Industry Human *Legislation, Drug *Prescriptions, Drug United States United States Food and Drug Administration



 




Information in this article was accurate in October 30, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.